| 1EQF |
2.1 |
CRYSTAL STRUCTURE OF THE DOUBLE BROMODOMAIN MODULE FROM HUMAN TAFII250 |
| 3AAD |
3.3 |
Structure of the histone chaperone CIA/ASF1-double bromodomain complex linking histone modifications and site-specific histone eviction |
| 3UV4 |
1.89 |
Crystal Structure of the second bromodomain of human Transcription initiation factor TFIID subunit 1 (TAF1) |
| 3UV5 |
2.03 |
Crystal Structure of the tandem bromodomains of human Transcription initiation factor TFIID subunit 1 (TAF1) |
| 4RGW |
2.301 |
Crystal Structure of a TAF1-TAF7 Complex in Human Transcription Factor IID |
| 4YYM |
1.5 |
Crystal structure of TAF1 BD2 Bromodomain bound to a butyryllysine peptide |
| 4YYN |
1.85 |
Crystal structure of TAF1 BD2 Bromodomain bound to a crotonyllysine peptide |
| 5FUR |
8.5 |
Structure of human TFIID-IIA bound to core promoter DNA |
| 5I1Q |
1.5 |
Second bromodomain of TAF1 bound to a pyrrolopyridone compound |
| 5I29 |
1.21 |
TAF1(2) bound to a pyrrolopyridone compound |
| 5MG2 |
1.75 |
Crystal structure of the second bromodomain of human TAF1 in complex with BAY-299 chemical probe |
| 6BQD |
2.136 |
TAF1-BD2 bromodomain in complex with (E)-3-(6-(but-2-en-1-yl)-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)-N,N-dimethylbenzamide |
| 6FIC |
2.18 |
Bivalent Inhibitor UNC4512 Bound to the TAF1 Bromodomain Tandem |
| 6MZD |
9.8 |
Human TFIID Lobe A canonical |
| 6MZL |
23.0 |
Human TFIID canonical state |
| 6MZM |
7.5 |
Human TFIID bound to promoter DNA and TFIIA |
| 6P38 |
2.8 |
Crystal Structure Analysis of TAF1 Bromodomain |
| 6P39 |
2.941 |
Crystal Structure Analysis of TAF1 Bromodomain |
| 6P3A |
2.99 |
Crystal Structure Analysis of TAF1 Bromodomain |
| 7EDX |
4.5 |
p53-bound TFIID-based core PIC on HDM2 promoter |
| 7EG7 |
6.2 |
TFIID-based core PIC on SCP promoter |
| 7EG8 |
7.4 |
TFIID-based core PIC on PUMA promoter |
| 7EG9 |
3.7 |
TFIID-based intermediate PIC on SCP promoter |
| 7EGA |
4.1 |
TFIID-based intermediate PIC on PUMA promoter |
| 7EGB |
3.3 |
TFIID-based holo PIC on SCP promoter |
| 7EGC |
3.9 |
p53-bound TFIID-based holo PIC on HDM2 promoter |
| 7EGD |
6.75 |
SCP promoter-bound TFIID-TFIIA in initial TBP-loading state |
| 7EGE |
9.0 |
TFIID in canonical conformation |
| 7EGH |
3.04 |
TFIID lobe C subcomplex |
| 7EGI |
9.82 |
TFIID in rearranged conformation |
| 7EGJ |
8.64 |
SCP promoter-bound TFIID-TFIIA in post TBP-loading state |
| 7ENA |
4.07 |
TFIID-based PIC-Mediator holo-complex in pre-assembled state (pre-hPIC-MED) |
| 7ENC |
4.13 |
TFIID-based PIC-Mediator holo-complex in fully-assembled state (hPIC-MED) |
| 7JJG |
1.6 |
Crystal structure of the second bromodomain (BD2) of human TAF1 bound to ATR kinase inhibitor AZ20 |
| 7JJH |
2.1 |
Crystal structure of the unliganded tandem bromodomain (BD1, BD2) of human TAF1 |
| 7JSP |
1.7 |
Crystal structure of the second bromodomain (BD2) of human TAF1 bound to ATR kinase inhibitor AZD6738 |
| 7JTC |
2.05 |
Crystal structure of the second bromodomain (BD2) of human TAF1 bound to ZS1-322 |
| 7K03 |
1.6 |
Crystal structure of the tandem bromodomain (BD1 and BD2) of human TAF1 bound to ATR kinase inhibitor AZD6738 |
| 7K0D |
2.2 |
Crystal structure of the tandem bromodomain (BD1, BD2) of human TAF1 bound to mTORC1/2 inhibitor AZD3147 |
| 7K0U |
2.52 |
Crystal structure of the second bromodomain (BD2) of human TAF1 bound to PLK1 kinase inhibitor BI2536 |
| 7K1P |
2.45 |
Crystal structure of the second bromodomain (BD2) of human TAF1 bound to bromosporine |
| 7K27 |
1.5 |
Crystal structure of the tandem bromodomain (BD1, BD2) of human TAF1 bound to ATR inhibitor AZ20 |
| 7K3O |
1.7 |
Crystal structure of the unliganded second bromodomain (BD2) of human TAF1 |
| 7K42 |
1.7 |
Crystal structure of the second bromodomain (BD2) of human TAF1 bound to dioxane |
| 7K6F |
1.86 |
Crystal structure of the tandem bromodomain (BD1, BD2) of human TAF1 in complex with MES (2-(N-morpholino)ethanesulfonic acid) |
| 7L6X |
2.75 |
Crystal structure of the tandem bromodomain (BD1, BD2) of human TAF1 bound to GNE-371 |
| 7LB0 |
2.33 |
Crystal structure of the tandem bromodomain (BD1, BD2) of human TAF1 bound to ZS1-295 |
| 7LB1 |
1.35 |
Crystal structure of the tandem bromodomain (BD1, BD2) of human TAF1 bound to ZS1-585 |
| 7LB2 |
1.7 |
Crystal structure of the tandem bromodomain (BD1, BD2) of human TAF1 bound to ZS1-589 |
| 7LB3 |
1.9 |
Crystal structure of the second bromodomain (BD2) of human TAF1 bound to ZS1-580 |
| 7N42 |
1.9 |
Crystal structure of the tandem bromodomain of human TAF1 (TAF1-T) bound to ZS1-681 |
| 7P4S |
2.17 |
BROMODOMAIN OF HUMAN TAF1 (2) WITH naphthyridinone compound |
| 7T2I |
1.89 |
Crystal structure of the tandem bromodomain (BD1, BD2) of human TAF1 bound to ZS1-588 |
| 7T36 |
1.65 |
Crystal structure of the tandem bromodomain (BD1 and BD2) of human TAF1 bound to ZS1-322 |
| 8GXQ |
5.04 |
PIC-Mediator in complex with +1 nucleosome (T40N) in MH-binding state |
| 8GXS |
4.16 |
PIC-Mediator in complex with +1 nucleosome (T40N) in H-binding state |
